期刊文献+

耐甲氧西林凝固酶阴性葡萄球菌及糖肽类耐药的检测与分析 被引量:14

Meticillin Resistance and Glycopeptide Resistance in Clinical Coagulase-negative Staphylococci:Detection and Analysis
下载PDF
导出
摘要 目的了解中日友好医院临床耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)糖肽类耐药的流行情况和耐药机制,为MRCNS医院感染的预防与控制提供可靠依据。方法头孢西丁纸片法、mecA基因PCR检测MRCNS;万古霉素耐药确证试验筛选对万古霉素敏感性下降的凝固酶阴性葡萄球菌(CNS),E-test法检测其MIC及多重PCR检测其van基因。结果CNS对头孢类、β-内酰胺类、氨基糖苷类、大环内酯类、克林霉素类抗菌药物耐药程度较高;52株CNS菌中头孢西丁纸片法与mecA基因检测MRCNS的符合率为96.2%,mecA基因阳性率为92.3%;256株CNS菌中筛选出4株异质性耐万古霉素葡萄球菌(VRS),均为MRCNS,未检出vanA、vanB、vanC1及vanC2基因。结论对VRS和MRCNS进行有效的实验室检测与院内监测并采取有效措施预防与控制其传播是非常重要的。 OBJECTIVE To provide laboratory evidence for the prevention and control of coagulase-negative staphylococci(CNS) and study the prevalence of meticillin resistance and vancomycin resistance in clinical CNS in our hospital. METHODS Meticillin-resistant coagulase-negative staphylococci (MRCNS) were detected with cefoxitin disk diffusion and mecA-PCR. CNS with reduced susceptibilities to vancomycin was detected with vancomycin agar screen test. Their MIC was determined with E-test and gene van was detected with multiplex PCR. RESULTS CNS was highly resistant to cephem, β-lactam, aminoglycoside, macrolide, and lincosamide. The confirm rate of cefoxitin disk diffusion to mecA-PCR was 96.2% and 92.3% of mecA in 52 CNS strains were detected. Four strains of staphylococci with heteroresistance to vancomycin (VRS) were screened in 256 CNS ones which were all MRCNS but without gene van detected. CONCLUSIONS It is important for clinical laboratory to detect VRS and MRCNS with suitable methods to prevent VRS infection and prevalence.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第9期1152-1155,共4页 Chinese Journal of Nosocomiology
基金 首都医学发展科研基金项目(2002-2019)
关键词 凝固酶阴性葡萄球菌 耐甲氧西林凝固酶阴性葡萄球菌 MECA基因 van基因 异质性耐万古霉素葡萄球菌 Coagulase-negative staphylococci Meticillin-resistant coagulase-negative staphylococci mecA van Staphylococci with heteroresistance to vancomycin
  • 相关文献

参考文献6

  • 1Kampf G,Dema S,Uden H,et al.Inducible and potential role of mecA-gene-positive oxacillin-susceptible Staphylococcus aureus from colonized healthcare workers as a source for nosocomial infections[J].J Hosp Infect,2003,54 (2):124-130.
  • 2National Committee for Clinical Laboratory Standards.Performance standards for antimicrobial susceptibility testing[S].Fifteenth informational supplement.M100-S15.NCCLS,2005.46.
  • 3Felten A,Grandry B,Lagrange PH.Evaluation of three techniques detection of low-level methicillin-resistant Staphylococcus aureus (MRSA):a disk diffusion method with cefoxitin and moxalactam,the VITEK 2 system,and the MRSA-screen latex agglutination test[J].J Clin Microbiol,2002,40:2766-2771.
  • 4ADA Council on Scientific Affairs.Combating antibiotic resistance[J].J Am Dent Assoc,2004,135(4):484-487.
  • 5Huang V,Brown WJ,Rybak MJ.In vitro activities of a novel cephalosporin,CB-181963 (CAB-175),against methicillinsusceptible or-resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci[J].Antimicrob Agents Chemother,2004,48(7):2719-2723.
  • 6Nishi H,Komatsuzawa H,Fujiwara T,et al.Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin,as well as vancomycin,gentamicin,and antimicrobial peptides,in Staphylococcus aureus[J].Antimicrob Agents Chemother,2004,48(12):4800-4807.

同被引文献92

引证文献14

二级引证文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部